Eczema ointment, Eucrisa, receives FDA nod
by Press Release from Outbreak News Today on (#2595N)
The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older. Atopic dermatitis, a chronic inflammatory skin disease, is often referred to as "eczema," which is a general term for the several types of inflammation of the skin. Atopic ["]
The post Eczema ointment, Eucrisa, receives FDA nod appeared first on Outbreak News Today.